CD19 and systemic sclerosis: 39013470 39013470 Wang X, Wu X, Tan B, Zhu L, Zhang Y, Lin L et al (2024) Allogeneic CD19-targeted CAR‐T therapy in patients with severe myositis and systemic sclerosis.